Han Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Gut microbiota and health 9
-
- Gastric Cancer Management and Outcomes 8
- Kidney Stones and Urolithiasis Treatments 7
- Co-authors
- Yong Xiao (1 shared paper)Zhixiang Chen (1 shared paper)Zhibing Lai (1 shared paper)Junwei Shi (1 shared paper)Xinping Xu (1 shared paper)Xiaoying Zhou (29 shared papers)Ye Yao (2 shared papers)Ning Wu (1 shared paper)
- Journals
- Medicine (5 papers)Journal of Cancer (4 papers)PLoS ONE (3 papers)Aging (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Han Chen
186 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 152
- Cancer Research 556
- Hepatology 190
- Molecular Biology 1.5k
- Health, Toxicology and Mutagenesis 200
- Ophthalmology 102
Countries citing papers authored by Han Chen
This map shows the geographic impact of Han Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Chen more than expected).
Fields of papers citing papers by Han Chen
This network shows the impact of papers produced by Han Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Chen. The network helps show where Han Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Han Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 432 | |
| 2 | 2020 | 195 | |
| 3 | 2004 | 169 | |
| 4 | 2019 | 139 | |
| 5 | 2019 | 105 | |
| 6 | Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. | 2007 | 104 |
| 7 | 2015 | 99 | |
| 8 | 2018 | 93 | |
| 9 | 2022 | 90 | |
| 10 | 2004 | 87 | |
| 11 | 2013 | 85 | |
| 12 | 2015 | 84 | |
| 13 | 2011 | 70 | |
| 14 | 2011 | 67 | |
| 15 | 2021 | 64 | |
| 16 | 2016 | 63 | |
| 17 | 2018 | 60 | |
| 18 | 2015 | 55 | |
| 19 | 2016 | 53 | |
| 20 | Interplay between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates proliferation and migration of colorectal cancer cells. | 2018 | 53 |
About Han Chen
Han Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Oncology, having authored 199 papers that have together received 3.9k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (10 papers), Gut microbiota and health (9 papers), Gastric Cancer Management and Outcomes (8 papers), Kidney Stones and Urolithiasis Treatments (7 papers), Cancer-related molecular mechanisms research (6 papers), Helicobacter pylori-related gastroenterology studies (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (556 citations), Hepatology (190 citations), Molecular Biology (1.5k citations), Health, Toxicology and Mutagenesis (200 citations) and Ophthalmology (102 citations). Han Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yong Xiao, Zhixiang Chen, Zhibing Lai, Junwei Shi, Xinping Xu, Xiaoying Zhou, Ye Yao, Ning Wu, Wenbo Wang and Lijing L. Yan. Their work appears in journals such as Medicine, Journal of Cancer, PLoS ONE, Aging and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.